Pages that link to "Q48332221"
Jump to navigation
Jump to search
The following pages link to Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain (Q48332221):
Displaying 30 items.
- Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT (Q26749755) (← links)
- "Is dopamine involved in Alzheimer's disease?" (Q26851680) (← links)
- Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases (Q28066691) (← links)
- Related genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray. (Q30357425) (← links)
- Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study (Q33302616) (← links)
- Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi (Q33848114) (← links)
- Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? (Q34121565) (← links)
- Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients (Q34393100) (← links)
- The relationship between dopamine receptor D1 and cognitive performance (Q36848267) (← links)
- Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease (Q36869427) (← links)
- Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals. (Q36980901) (← links)
- The potential role of dopamine D₃ receptor neurotransmission in cognition. (Q37106827) (← links)
- Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase (Q37212345) (← links)
- Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease (Q37630546) (← links)
- The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. (Q37766266) (← links)
- CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD. (Q38012590) (← links)
- Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity (Q38062799) (← links)
- Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets. (Q38430656) (← links)
- Catecholamine-Based Treatment in AD Patients: Expectations and Delusions. (Q38497202) (← links)
- Development of a dopaminergic system in sea urchin embryos and larvae (Q42475223) (← links)
- Modulation of dopamine‐dependent behaviors by the Caenorhabditis elegans Olig homolog HLH‐17 (Q42490242) (← links)
- Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. (Q45974067) (← links)
- L-dopa modulates motor cortex excitability in Alzheimer's disease patients (Q46506870) (← links)
- Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients (Q47881491) (← links)
- Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL. (Q53462880) (← links)
- Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs (Q91430533) (← links)
- White Matter Hyperintensities Relate to Basal Ganglia Functional Connectivity and Memory Performance in aMCI and SVMCI (Q91669354) (← links)
- Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation (Q91763700) (← links)
- Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis (Q92237879) (← links)
- Monoaminergic System Modulation in Depression and Alzheimer's Disease: A New Standpoint? (Q92478210) (← links)